CRE and the Life Sciences Boom
Abstract
In 2020, pharma, R&D, and medical technology raced to develop new therapies and vaccines for COVID-19, which may have been the tipping point that led to the life sciences boom. In 2021, a record $78 billion of private equity and public investments was pumped into life science-related companies. The biotech research and development subsector experienced more than 11% growth in employment. Look for more traditional and non-traditional players to enter the life science game, like Amazon’s recent purchase of One Medical and One Medical, which will only increase the pressure for workers and space.
You can contact us to get more choices
